Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).

Suppr

超能文献

作者信息

Plotnikoff N P, Kastin A J, Anderson M S, Schally A V

出版信息

Proc Soc Exp Biol Med. 1972 Jul;140(3):811-4. doi: 10.3181/00379727-140-36558.

DOI:10.3181/00379727-140-36558

PMID:5064701

Abstract

摘要

相似文献

Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).

Proc Soc Exp Biol Med. 1972 Jul;140(3):811-4. doi: 10.3181/00379727-140-36558.

Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.

Arch Int Pharmacodyn Ther. 1972 Apr;196(2):376-82.

Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.

Acta Pharm Suec. 1972 Apr;9(2):93-8.

The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.

Arch Int Pharmacodyn Ther. 1972 May;197(1):108-11.

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

Life Sci I. 1971 Nov 15;10(22):1279-83. doi: 10.1016/0024-3205(71)90326-2.

Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa.

Life Sci I. 1972 Jun 1;11(11):535-44. doi: 10.1016/0024-3205(72)90004-5.

Antagonism of centrally mediated oxotremorine effects by a peripherally acting drug.

Eur J Pharmacol. 1971;15(3):310-7. doi: 10.1016/0014-2999(71)90097-5.

Effect of L-5HTP on tremorine- or oxotremorine-induced tremor in mice and rats.

Jpn J Pharmacol. 1973 Dec;23(6):901-3. doi: 10.1254/jjp.23.901.

Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.

J Med Chem. 1979 Aug;22(8):931-5. doi: 10.1021/jm00194a009.

Synthesis and pharmacological properties of 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1,2-dialkylpyrrolidine derivatives.

J Med Chem. 1972 Sep;15(9):891-4. doi: 10.1021/jm00279a004.

引用本文的文献

Concepts for biologically active peptides.

Curr Pharm Des. 2010 Oct;16(30):3390-400. doi: 10.2174/138161210793563491.

Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.

Peptides. 2009 Jul;30(7):1276-81. doi: 10.1016/j.peptides.2009.04.004. Epub 2009 Apr 11.

Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Drugs. 1973;6(5):364-88. doi: 10.2165/00003495-197306050-00004.

Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.

Can Med Assoc J. 1972 Dec 9;107(11):1079-81.

MSH-release inhibiting factors: recent studies.

Yale J Biol Med. 1973 Dec;46(5):617-22.

Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.

Proc Natl Acad Sci U S A. 1975 Oct;72(10):4180-4. doi: 10.1073/pnas.72.10.4180.

Effects of arecoline and cholinesterase inhibitors on cyclic guanosine 3',5'-monophosphate and adenosine 3'.5'-monophosphate in mouse brain.

Naunyn Schmiedebergs Arch Pharmacol. 1975;290(2-3):297-306. doi: 10.1007/BF00510558.

Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Psychopharmacology (Berl). 1979 Jun 21;63(3):217-22. doi: 10.1007/BF00433553.

On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.

Naunyn Schmiedebergs Arch Pharmacol. 1977 Jun;298(2):79-81. doi: 10.1007/BF00508614.

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

Can Med Assoc J. 1976 Jan 24;114(2):120-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验